Literature DB >> 24554384

Reply to the letter "Need for supplementary data in a recent meta-analysis about risk of venous thromboembolism in patients with rheumatoid arthritis".

Patompong Ungprasert1, Narat Srivali, Ittikorn Spanuchart, Charat Thongprayoon, Eric L Knight.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24554384     DOI： 10.1007/s10067-014-2532-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  5 in total

1.  Need for supplementary data in a recent meta-analysis about risk of venous thromboembolism in patients with rheumatoid arthritis.

Authors:  Yanqiong Liu; Ruolin Li; Jian Wang; Xue Qin; Shan Li
Journal:  Clin Rheumatol       Date:  2014-02-07       Impact factor: 2.980

2.  Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Lancet       Date:  2011-11-25       Impact factor: 79.321

Review 3.  Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Narat Srivali; Ittikorn Spanuchart; Charat Thongprayoon; Eric L Knight
Journal:  Clin Rheumatol       Date:  2014-01-15       Impact factor: 2.980

4.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Authors:  W Miehsler; W Reinisch; E Valic; W Osterode; W Tillinger; T Feichtenschlager; J Grisar; K Machold; S Scholz; H Vogelsang; G Novacek
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

5.  Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study.

Authors:  Sreeram V Ramagopalan; Clare J Wotton; Adam E Handel; David Yeates; Michael J Goldacre
Journal:  BMC Med       Date:  2011-01-10       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.